InvestorsHub Logo
Followers 6
Posts 137
Boards Moderated 0
Alias Born 11/27/2018

Re: MateoPaisa post# 192222

Sunday, 05/19/2019 2:48:04 PM

Sunday, May 19, 2019 2:48:04 PM

Post# of 429168
I agree, nothing is ever a slam dunk w/ FDA. Including priority review. I think we’ll get it, but wouldn’t be shocked if we did not.

Chance of rejection due to a technical issue, or incomplete application would be very low.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News